MPM Oncology Impact Management

BioImpact Capital as of Sept. 30, 2021

Portfolio Holdings for BioImpact Capital

BioImpact Capital holds 33 positions in its portfolio as reported in the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cullinan Oncology Common (CGEM) 26.8 $173M 7.6M 22.57
iTeos Therapeutics Common (ITOS) 8.8 $57M 2.1M 27.00
Repare Therapeutics Common (RPTX) 6.7 $43M 1.6M 26.24
Werewolf Therapeutics Common (HOWL) 6.4 $41M 2.4M 17.16
MEI Pharma Common 5.3 $35M 13M 2.76
TCR2 Therapeutics Common 4.4 $29M 3.4M 8.51
Harpoon Therapeutics Common 3.9 $25M 3.2M 7.90
Oncorus Common 3.4 $22M 2.4M 9.34
Intellia Therapeutics Common (NTLA) 3.4 $22M 163k 134.15
Merus Common (MRUS) 3.2 $21M 942k 22.00
Epizyme Common 3.2 $20M 4.0M 5.12
Turning Point Therapeutics Common 2.8 $18M 271k 66.43
YmAbs Therapeutics Common (YMAB) 2.0 $13M 453k 28.54
G1 Therapeutics Common (GTHX) 1.8 $12M 861k 13.42
Biocryst Pharmaceuticals Common (BCRX) 1.6 $10M 705k 14.37
ADC Therapeutics Common (ADCT) 1.5 $9.4M 345k 27.16
Cytokinetics Common (CYTK) 1.4 $8.8M 247k 35.74
Verastem Common 1.3 $8.7M 2.8M 3.08
Geron Corporation Common (GERN) 1.2 $7.9M 5.7M 1.37
Travere Therapeutics Common (TVTX) 1.2 $7.4M 307k 24.25
Neogenomics Common (NEO) 1.1 $7.2M 150k 48.24
Crinetics Pharmaceuticals Common (CRNX) 1.0 $6.3M 298k 21.05
Mirum Pharmaceuticals Common (MIRM) 1.0 $6.1M 309k 19.92
Harmony Biosciences Hldgs Common (HRMY) 0.9 $5.8M 152k 38.33
ESSA Pharma Common (EPIX) 0.8 $5.5M 683k 8.00
Amicus Therapeutics Common (FOLD) 0.8 $5.2M 547k 9.55
Avrobio Common (AVRO) 0.7 $4.8M 862k 5.58
Lucira Health Common 0.7 $4.4M 578k 7.60
Revolution Medicines Common (RVMD) 0.6 $4.1M 150k 27.51
Avadel Pharmaceuticals Common (AVDL) 0.6 $3.9M 400k 9.80
Inozyme Pharma Common (INZY) 0.6 $3.7M 321k 11.59
Axsome Therapeutics Common (AXSM) 0.6 $3.6M 110k 32.96
Black Diamond Therapeutics Common (BDTX) 0.3 $2.1M 249k 8.46